-951-55a57153.jpg "Medication-Related Osteonecrosis of the Jaws: Bisphosphonates, Denosumab, and New Agents (pdf)")
|
Medication-Related Osteonecrosis of the Jaws: Bisphosphonates, Denosumab, and New Agents (pdf)Author : Sven Otto (Editor)Medication-Related Osteonecrosis of the Jaws: Bisphosphonates, Denosumab, and New Agents (pdf) Osteonecrosis of the jaws is a well-known side-effect of anti-resorptive therapy that predominantly occurs in patients suffering from malignant diseases and receiving intravenous administrations of nitrogen-containing bisphosphonates or --subcutaneous administrations of denosumab, a monoclonal antibody. Less frequently it may also be observed in patients with osteoporosis who are being treated with these anti-resorptive drugs. This textbook provides detailed, up-to-date information on all aspects of medication-related osteonecrosis of the jaws, including clinical features, pathogenesis, treatment options, and preventive measures. It also explains safe prevention and treatment strategies for patients receiving anti-resorptive drugs who require extractions, implant insertions, and other dento-alveolar surgeries. This book will be of major interest for medical and dental students, dentists, and oral and maxillofacial surgeons as well as osteologists and oncologists. |
| Views : 13653 |
-847-f87e182d.jpg)
